Platelet-derived Growth Factor Receptor alpha Antagonist
- Name
- Platelet-derived Growth Factor Receptor alpha Antagonist
- Accession Number
- DBCAT005838
- Description
Not Available
- Drugs
Drug Drug Description Olaratumab A platelet-derived growth factor receptor alpha blocking antibody used with doxorubicin to treat patients with certain types of soft tissue sarcoma (STS). - Drugs & Drug Targets
Drug Target Type Olaratumab Platelet-derived growth factor receptor alpha target